Imamura K, Nagahashi A, Okusa A, Sakasai T, Tsukita K, Kutoku Y, Ohsawa Y, Sunada Y, Sahara N, Kanaan NM, Higuchi M, Mori K, Ikeda M, Inoue H. iPSC screening identifies CACNA2D2 as a potential therapeutic target for FTLD-Tau. Eur J Cell Biol. 2025 Mar 21;104(2):151484. Epub 2025 Mar 21 PubMed.
Recommends
Please login to recommend the paper.
Comments
No Available Comments
Make a Comment
To make a comment you must login or register.